Antibodies, Monoclonal, HumanizedReceptor, erbB-2Chemotherapy, AdjuvantBreast NeoplasmsAntibodies, MonoclonalAntineoplastic AgentsAdjuvants, ImmunologicQuality-Adjusted Life YearsAntineoplastic Combined Chemotherapy ProtocolsDisease-Free SurvivalIn Situ Hybridization, FluorescenceTreatment OutcomeMarkov ChainsNeoplasm StagingNeoplasm Recurrence, LocalRandomized Controlled Trials as TopicFreund's AdjuvantGenes, erbB-2MaytansineRadiotherapy, AdjuvantAnthracyclinesAdjuvants, PharmaceuticDrug Resistance, NeoplasmTaxoidsCell Line, TumorPaclitaxelNeoplasm MetastasisQuinazolinesNeoadjuvant TherapyCyclophosphamideFluorouracilEpirubicinCombined Modality TherapyPrognosisSurvival AnalysisAntibody-Dependent Cell CytotoxicityTamoxifenGene AmplificationXenograft Model Antitumor AssaysAluminum HydroxideDoxorubicinAntineoplastic Agents, HormonalCardiotoxinsDrug Administration ScheduleVinblastineMice, NudeSurvival RateLymphatic MetastasisKaplan-Meier EstimateDrug SynergismReceptors, EstrogenMice, Inbred BALB CDeoxycytidineImmunohistochemistryReceptor, erbB-3Fractionation, Field FlowAromatase InhibitorsClinical Trials as TopicImmunizationLead RadioisotopesTumor Markers, BiologicalRetrospective StudiesActiniumGene Expression Regulation, NeoplasticImmunoglobulin SubunitsMolecular Targeted TherapyCarcinoma, Ductal, BreastHeart DiseasesPTEN PhosphohydrolaseReceptors, ProgesteroneDisease ProgressionMastectomyTime FactorsIndium RadioisotopesVaccinesAdministration, IntranasalCell ProliferationReceptor, Epidermal Growth FactorNitrilesDose-Response Relationship, DrugFollow-Up StudiesAnimal Use AlternativesCentral Nervous System NeoplasmsClinical Trials, Phase III as TopicSignal TransductionImmunoglobulin GAstatineAdenocarcinomaBridged CompoundsMeningeal CarcinomatosisTriazolesArthritis, ExperimentalCancer VaccinesCarboplatinAntibody FormationInfusions, IntravenousBrain NeoplasmsFlow CytometryStomach NeoplasmsProportional Hazards Models